282 related articles for article (PubMed ID: 22126626)
1. Adverse interactions between antifungal azoles and vincristine: review and analysis of cases.
Moriyama B; Henning SA; Leung J; Falade-Nwulia O; Jarosinski P; Penzak SR; Walsh TJ
Mycoses; 2012 Jul; 55(4):290-7. PubMed ID: 22126626
[TBL] [Abstract][Full Text] [Related]
2. Modification of vincristine dosing during concomitant azole therapy in adult acute lymphoblastic leukemia patients.
Harnicar S; Adel N; Jurcic J
J Oncol Pharm Pract; 2009 Sep; 15(3):175-82. PubMed ID: 19282418
[TBL] [Abstract][Full Text] [Related]
3. Posaconazole-increased vincristine neurotoxicity in a child: a case report.
Eiden C; Palenzuela G; Hillaire-Buys D; Margueritte G; Cociglio M; Hansel-Esteller S; Peyriere H
J Pediatr Hematol Oncol; 2009 Apr; 31(4):292-5. PubMed ID: 19346885
[TBL] [Abstract][Full Text] [Related]
4. Severe life threatening neurotoxicity in a child with acute lymphoblastic leukemia receiving posaconazole and vincristine.
Jain S; Kapoor G
Pediatr Blood Cancer; 2010 May; 54(5):783. PubMed ID: 20205256
[No Abstract] [Full Text] [Related]
5. Severe neurological disorders and refractory aspergillosis in an adolescent treated by vincristine and voriconazole.
Bennis Y; Bodeau S; Lutun A; Gourmel A; Solas C; Quaranta S; Guillaume N; Chouaki T; Lemaire-Hurtel AS; Masmoudi K
J Clin Pharm Ther; 2018 Apr; 43(2):265-268. PubMed ID: 28795412
[TBL] [Abstract][Full Text] [Related]
6. Risk of azole-enhanced vincristine neurotoxicity in pediatric patients with hematological malignancies: old problem - new dilemma.
Pana ZD; Roilides E
Pediatr Blood Cancer; 2011 Jul; 57(1):30-5. PubMed ID: 21265011
[TBL] [Abstract][Full Text] [Related]
7. Severe vincristine neurotoxicity with concomitant use of itraconazole.
Ariffin H; Omar KZ; Ang EL; Shekhar K
J Paediatr Child Health; 2003 Nov; 39(8):638-9. PubMed ID: 14629538
[No Abstract] [Full Text] [Related]
8. Clinical Analysis of Adverse Drug Reactions between Vincristine and Triazoles in Children with Acute Lymphoblastic Leukemia.
Yang L; Yu L; Chen X; Hu Y; Wang B
Med Sci Monit; 2015 Jun; 21():1656-61. PubMed ID: 26050202
[TBL] [Abstract][Full Text] [Related]
9. Effect of azole antifungal therapy on vincristine toxicity in childhood acute lymphoblastic leukaemia.
van Schie RM; Brüggemann RJ; Hoogerbrugge PM; te Loo DM
J Antimicrob Chemother; 2011 Aug; 66(8):1853-6. PubMed ID: 21652620
[TBL] [Abstract][Full Text] [Related]
10. Potentiation of vincristine toxicity by itraconazole in children with lymphoid malignancies.
Kamaluddin M; McNally P; Breatnach F; O'Marcaigh A; Webb D; O'Dell E; Scanlon P; Butler K; O'Meara A
Acta Paediatr; 2001 Oct; 90(10):1204-7. PubMed ID: 11697438
[TBL] [Abstract][Full Text] [Related]
11. Aggravation of vincristine-induced neurotoxicity by itraconazole in the treatment of adult ALL.
Böhme A; Ganser A; Hoelzer D
Ann Hematol; 1995 Dec; 71(6):311-2. PubMed ID: 8534764
[TBL] [Abstract][Full Text] [Related]
12. Antifungal Therapy with Azoles Induced the Syndrome of Acquired Apparent Mineralocorticoid Excess: a Literature and Database Analysis.
Ji HH; Tang XW; Zhang N; Huo BN; Liu Y; Song L; Jia YT
Antimicrob Agents Chemother; 2022 Jan; 66(1):e0166821. PubMed ID: 34662186
[TBL] [Abstract][Full Text] [Related]
13. Itraconazole-enhanced vincristine neurotoxicity in a child with acute lymphoblastic leukemia.
Jeng MR; Feusner J
Pediatr Hematol Oncol; 2001 Mar; 18(2):137-42. PubMed ID: 11255732
[TBL] [Abstract][Full Text] [Related]
14. [A retrospective analysis of neurotoxicity induced by vinca alkaloids combined with azole anti-fungal agents in hematological malignancies].
Osato Y; Yokoyama T; Saito Y; Kani R; Hayabe H; Miyamatsu H; Ohyashiki K
Gan To Kagaku Ryoho; 2011 Oct; 38(10):1667-72. PubMed ID: 21996963
[TBL] [Abstract][Full Text] [Related]
15. Vincristine-associated Neuropathy With Antifungal Usage: A Kaiser Northern California Experience.
Nikanjam M; Sun A; Albers M; Mangalindin K; Song E; Vempaty H; Sam D; Capparelli EV
J Pediatr Hematol Oncol; 2018 Jul; 40(5):e273-e277. PubMed ID: 29771861
[TBL] [Abstract][Full Text] [Related]
16. Adverse Effects Associated with Long-Term Administration of Azole Antifungal Agents.
Benitez LL; Carver PL
Drugs; 2019 Jun; 79(8):833-853. PubMed ID: 31093949
[TBL] [Abstract][Full Text] [Related]
17. Azole antifungals: 35 years of invasive fungal infection management.
Allen D; Wilson D; Drew R; Perfect J
Expert Rev Anti Infect Ther; 2015 Jun; 13(6):787-98. PubMed ID: 25843556
[TBL] [Abstract][Full Text] [Related]
18. Update on drug interactions with azole antifungal agents.
Lomaestro BM; Piatek MA
Ann Pharmacother; 1998 Sep; 32(9):915-28. PubMed ID: 9762380
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic drug interactions of vinca alkaloids: summary of case reports.
Chan JD
Pharmacotherapy; 1998; 18(6):1304-7. PubMed ID: 9855331
[TBL] [Abstract][Full Text] [Related]
20. Skin Allergy to Azole Antifungal Agents for Systemic Use: A Review of the Literature.
Calogiuri G; Garvey LH; Nettis E; Romita P; Di Leo E; Caruso R; Butani L; Foti C
Recent Pat Inflamm Allergy Drug Discov; 2019; 13(2):144-157. PubMed ID: 31538908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
